公开(公告)号：KR1019900003562B1

公开(公告)日：1990-05-21

申请号：KR1019870014208

申请日：1987-12-22

Applicant: 한국과학기술연구원

Inventor： 장문호 ,  고훈영 ,  최경일

IPC: C07D501/20 ,  C07D501/22 ,  C07D501/34

Abstract: Silly cephalosporin derivs. having formula (I) are new. (I) are prepd. by reacting sillyl cpds. with cephalosporin in the presence of org. solvent (i.e. acetone, dioxane, THF) and acid (i.e. formic acid, acetic acid, propionic acid) or base (i.e. alkali metal hydroxide, N,N-di (lower)-alkylbenzyl amine) at 0-25 deg. C. In (I), R=H or trithyl; R2= acetoxymethyl or vinyl; R3= H or Na; n= 1; X= Y= Z=Me. (I) show broad spectrum against gram positive and gram negative.

Abstract translation: 愚蠢头孢菌素衍生物。 具有式（I）的化合物是新的。 （I）是prepd。 通过使硅烷基cpds反应。 头孢菌素在组织的存在下。 溶剂（即丙酮，二恶烷，THF）和酸（即甲酸，乙酸，丙酸）或碱（即碱金属氢氧化物，N，N-二（低级 - 烷基苄基胺））在0-25℃。 C.（I）中，R = H或三硫代基; R2 =乙酰氧基甲基或乙烯基; R3 = H或Na; n = 1; X = Y = Z = Me。 （I）显示广谱对革兰氏阳性和革兰氏阴性。

公开(公告)号：KR1019890009940A

公开(公告)日：1989-08-05

申请号：KR1019870014208

申请日：1987-12-22

Applicant: 한국과학기술연구원

Inventor： 장문호 ,  고훈영 ,  최경일

IPC: C07D501/20 ,  C07D501/22 ,  C07D501/34

Abstract: 내용 없음

公开(公告)号：KR1020150131647A

公开(公告)日：2015-11-25

申请号：KR1020140058621

申请日：2014-05-15

Applicant: 한국과학기술연구원

Inventor： 남길수 ,  최경일 ,  김정현 ,  배애님 ,  홍진리 ,  이재균

IPC: C07D231/10 ,  C07D417/06 ,  A61K31/415

CPC classification number: C07D231/12 ,  C07D401/12 ,  C07D417/06 ,  C07D417/14

Abstract: 본발명은칼슘이온채널조절제로서유효한-(피라졸릴메틸)아릴설폰아마이드유도체및 이의약제학적으로허용가능한염, 그리고이 화합물이갖는칼슘이온채널억제효과에의한질환치료제로사용하는의약적용도에관한것이다.

Abstract translation: 本发明涉及可用作钙离子通道的控制剂并由化学式1表示的N-（吡唑基甲基）芳基磺酰胺衍生物。此外，本发明还涉及其药学上可接受的盐和医学上可接受的盐 用作治疗与化合物对钙离子通道的抑制作用相关的病症。

公开(公告)号：KR1020140134904A

公开(公告)日：2014-11-25

申请号：KR1020130054919

申请日：2013-05-15

Applicant: 한국과학기술연구원

Inventor： 남길수 ,  최경일 ,  배애님 ,  서선희 ,  추현아 ,  금교창 ,  김정현

IPC: C07D403/12 ,  C07D209/52 ,  A61K31/4155 ,  A61P25/00

CPC classification number: C07D403/12 ,  A61K31/4155

Abstract: 본 발명은 칼슘이온 채널 조절제로서 유효한 6-피라졸일아미도-3-치환된 아자바이사이클로[3.1.0]헥산 유도체 및 이의 약제학적으로 허용 가능한 염, 그리고 이 화합물이 갖는 칼슘이온 채널 억제 효과에 의한 질환 치료제로 사용하는 의약적 용도에 관한 것이다.

Abstract translation: 本发明涉及6-吡唑基氨基-3-取代的氮杂双环[3.1.0]己烷衍生物及其药学上可接受的盐，以及通过其化合物获得的钙离子通道抑制作用的疾病治疗中的药物用途。

公开(公告)号：KR1020130006554A

公开(公告)日：2013-01-17

申请号：KR1020110066569

申请日：2011-07-05

Applicant: 한국과학기술연구원

Inventor： 금교창 ,  김은경 ,  배애님 ,  최경일 ,  강순방 ,  서선희 ,  바타라이디팍 ,  이주현

IPC: C07D413/10 ,  C07D413/14 ,  A61K31/422 ,  A61P31/04

CPC classification number: C07D413/10 ,  A61K31/422 ,  C07D413/14 ,  Y02A50/473 ,  Y02A50/481

Abstract: PURPOSE: AN oxazolidinone derivative containing a novel cyclic group is provided to ensure excellent antibacterial activity against gram-positive bacteria including various resistant strains. CONSTITUTION: An oxazolidionone derivative containing a cyclopenta[c]pyloriphenyl group is denoted by chemical formula 1. An antibacterial composition contains the oxazolidinone derivative or a pharmaceutically acceptable salt thereof as an active ingredient. The antibacterial composition has antibacterial activity against Staphylococcus sp., Enterococcus sp., E.coli, Bacillus sp., Salmonella sp. or Mycobacterium.

Abstract translation: 目的：提供含有新环状基团的恶唑烷酮衍生物，以确保对包括各种抗性菌株在内的革兰氏阳性菌具有优异的抗菌活性。 构成：含有环戊二烯并[c]苯乙烯基的恶唑烷酮衍生物由化学式1表示。抗菌组合物含有恶唑烷酮衍生物或其药学上可接受的盐作为活性成分。 抗菌组合物对葡萄球菌属，肠球菌属，肠杆菌属，大肠杆菌属，芽孢杆菌属，沙门氏菌属， 或分枝杆菌。

公开(公告)号：KR1020120096842A

公开(公告)日：2012-08-31

申请号：KR1020110016203

申请日：2011-02-23

Applicant: 한국과학기술연구원

Inventor： 추현아 ,  배애님 ,  조용서 ,  이효선 ,  이지은 ,  조경희 ,  임혜원 ,  서선희 ,  송치만 ,  정혜진 ,  남길수 ,  금교창 ,  김동진 ,  최경일 ,  최기현 ,  이재균 ,  강용구 ,  박웅서 ,  이주현 ,  신선미 ,  아미드,압둘와히드 ,  김영수 ,  민선준

IPC: C07D413/12 ,  A61K31/496 ,  A61P25/00 ,  A61P9/00

CPC classification number: C07D413/12

Abstract: PURPOSE: A 5-(substituted alkylaminomethyl)isoxazole based compound as T-type calcium channel blocker is provided to have excellent activity as an antagonist of T- type calcium ion channel. CONSTITUTION: A 5-(substituted alkylaminomethyl)isoxazole based compound as T-type calcium channel blocker is represented by chemical formula 1. The encephalopathy therapy and for prevention agent selected from epilepsy, depression, Parkinson's disease, dementia, sleep disorder, an agent for cancer treatment and prevention, an agent for heart disease treatment and prevention selected from hypertensive, cardiac arrhythmia, angina, myocardial infarction, congestive heart failure, pharmaceutical composition for alleviating pain selected from neuropathic pain and chronic and acute pain includes a compound represented by chemical formula 1.

Abstract translation: 目的：提供作为T型钙通道阻滞剂的5-（取代的烷基氨基甲基）异恶唑基化合物作为T-型钙离子通道的拮抗剂具有优异的活性。 构成：以化学式1表示作为T型钙通道阻断剂的5-（取代烷基氨基甲基）异恶唑类化合物。脑病治疗和预防药物选自癫痫，抑郁症，帕金森病，痴呆，睡眠障碍， 癌症治疗和预防，选自高血压，心律失常，心绞痛，心肌梗塞，充血性心力衰竭，减轻选自神经性疼痛和慢性和急性疼痛的疼痛的药物组合物的心脏病治疗和预防剂，包括由化学式 1。

公开(公告)号：KR1020120088398A

公开(公告)日：2012-08-08

申请号：KR1020110009730

申请日：2011-01-31

Applicant: 한국과학기술연구원

Inventor： 배애님 ,  조용서 ,  추현아 ,  최경일 ,  김동진 ,  서선희 ,  임혜원 ,  최기현 ,  송치만 ,  김윤정 ,  임건승

IPC: C07D413/06 ,  C07D413/12 ,  A61K31/496 ,  A61P9/00

Abstract: PURPOSE: A pharmaceutical composition containing pentagonal heteroaromatic compound, a pharmaceutically acceptable salt thereof having a pharmaceutical activity to T-type calcium channel is provided to treat heart disease, brain diseases, stroma, chronic pain, neuropathic pain, and cancer. CONSTITUTION: A pentagonal heteroaromtaic compound with T-type calcium channel is denoted by chemical formula 1. A pharmaceutical composition for preventing and treating stroma, hypertension, angina, chronic pain, neuropathic pain, and cancer contains the compound as an active ingredient. A method for preparing the compound comprises a step of binding carbochloride compound of chemical formula 3a and heterocyclic amine compounds of chemical formula 2a under the presence of an alkyl amine base.

Abstract translation: 目的：提供含有对T型钙通道具有药学活性的五价杂芳族化合物及其药学上可接受的盐的药物组合物，用于治疗心脏病，脑疾病，基质，慢性疼痛，神经性疼痛和癌症。 构成：用化学式1表示具有T型钙通道的五价杂合化合物。用于预防和治疗基质，高血压，心绞痛，慢性疼痛，神经性疼痛和癌症的药物组合物含有该化合物作为活性成分。 制备该化合物的方法包括在烷基胺基的存在下结合化学式3a的氯化碳化合物和化学式2a的杂环胺化合物的步骤。

公开(公告)号：KR101064258B1

公开(公告)日：2011-09-14

申请号：KR1020080135519

申请日：2008-12-29

Applicant: 한국과학기술연구원

Inventor： 한호규 ,  남기달 ,  신동윤 ,  박찬호 ,  조성우 ,  김은아 ,  남길수 ,  최경일 ,  서선희 ,  신희섭 ,  김동진 ,  배애님 ,  정혜진 ,  추현아 ,  임혜원 ,  조용서 ,  노은주 ,  금교창 ,  최기현 ,  신계정 ,  정찬성 ,  이재균 ,  강용구 ,  김영수 ,  박웅서 ,  김기선 ,  정혜선 ,  송치만 ,  민선준 ,  김은경 ,  이철주 ,  강순방

IPC: C07D277/82 ,  C07D263/58 ,  C07D235/30 ,  A61P25/28

CPC classification number: C07D277/82 ,  C07D235/22 ,  C07D263/58 ,  C07D327/04 ,  C07D333/06

Abstract: 본 발명은 신규한 벤조아릴우레이도 화합물, 및 이의 퇴행성 뇌질환 예방 또는 치료에 있어서의 용도에 관한 것으로, 보다 상세하게는, 화학식 1의 구조를 갖는 벤조아릴우레이도 화합물, 및 이를 유효성분으로 함유하는 퇴행성 뇌질환의 예방 또는 치료용 조성물에 관한 것이다. 상기 퇴행성 뇌질환은 알츠하이머, 치매, 파킨슨병, 뇌졸중, 아밀로이드증, 픽 질환 (Pick's disease), 루게릭병, 헌팅턴병, 크로이츠펠트-야콥(Creutzfeld-Jakob)병 등일 수 있다.
[화학식 1]

公开(公告)号：KR1020110020023A

公开(公告)日：2011-03-02

申请号：KR1020090077687

申请日：2009-08-21

Applicant: 한국과학기술연구원

Inventor： 배애님 ,  추현아 ,  조용서 ,  이지은 ,  금교창 ,  최경일 ,  김동진 ,  신희섭 ,  임혜원 ,  정혜진 ,  서선희 ,  송치만

IPC: C07D413/12 ,  C07D413/10

Abstract: PURPOSE: An oxazole-piperazine compound having a pharmaceutical activity with respect to T-type calcium channel is provided to ensure excellent activity as an antagonist of the channel and to prevent and treat cancer, epilepsy, heart diseases, and pain. CONSTITUTION: An oxazole-piperazine compounds is denoted by chemical formula 1. A pharmaceutical composition for treating epilepsy, cancer, hypertension, myocardial infarction, neuropathic pain, and acute and chronic pain contains the oxazole-piperazine compound of chemical formula 1. The compound of chemical formula 1 is prepared by reacting piperazine-amine compound of chemical formula 2 and oxazole aldehyde compound of chemical formula 3 by reductive amination. The reductive amination is performed under the presence of molecules of 4-8 meshes and NaBH(OAc)_3, NaBH_3CN, or NaBH_4.

Abstract translation: 目的：提供相对于T型钙通道具有药学活性的恶唑 - 哌嗪化合物，以确保作为通道拮抗剂的优异活性，并预防和治疗癌症，癫痫，心脏病和疼痛。 构成：化学式1表示恶唑 - 哌嗪化合物。用于治疗癫痫，癌症，高血压，心肌梗死，神经性疼痛和急性和慢性疼痛的药物组合物含有化学式1的恶唑 - 哌嗪化合物。 化学式1通过化学式2的哌嗪 - 胺化合物和化学式3的恶唑醛化合物通过还原胺化反应来制备。 还原胺化在4-8目和NaBH（OAc）3，NaBH 3 CN或NaBH 4的分子存在下进行。

公开(公告)号：KR100879636B1

公开(公告)日：2009-01-21

申请号：KR1020070084322

申请日：2007-08-22

Applicant: 한국과학기술연구원

Inventor： 남길수 ,  임혜원 ,  배애님 ,  추현아 ,  최경일 ,  나승렬

IPC: A61K31/517 ,  A61P25/00

CPC classification number: A61K31/517 ,  A61K31/5377

Abstract: A pharmaceutical composition for preventing and treating the disease related to the central nervous system, and a food composition are provided to obtain the effect on emesis, nausea, alcoholism, drugs abuse, depression, compulsion neurosis, anxiety, etc. A pharmaceutical composition for preventing and treating the disease related to the central nervous system comprises a quinoline derivative compound represented by the formula 1 or its pharmaceutically acceptable salt as an active ingredient, wherein R1 is H, a C1-C6 alkyl group, a phenyl group or a benzyl group; R2 is a heterocyclic group selected from morpholine, pyrrolidine and piperidine; the phenyl group or the benzyl group can be substituted with a substituent selected from a halogen atom, a C1-C6 alkyl group and a C1-C6 alkoxy group; and n is an integer of 1-6.

Abstract translation: 提供了用于预防和治疗与中枢神经系统有关的疾病的药物组合物和食物组合物，以获得对呕吐，恶心，酒精中毒，药物滥用，抑郁，强迫性神经症，焦虑等的作用。 并且治疗与中枢神经系统相关的疾病包括由式1表示的喹啉衍生物化合物或其药学上可接受的盐作为活性成分，其中R1是H，C1-C6烷基，苯基或苄基; R2是选自吗啉，吡咯烷和哌啶的杂环基; 苯基或苄基可以被选自卤素原子，C1-C6烷基和C1-C6烷氧基的取代基取代; n为1-6的整数。